These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5845495)

  • 1. Role of citrate in abnormal copper metabolism.
    Nath R; Srivastava SK
    Metabolism; 1965 Dec; 14(12):1237-9. PubMed ID: 5845495
    [No Abstract]   [Full Text] [Related]  

  • 2. The contribution of citrate to the ferroxidase activity of serum.
    Lee GR; Nacht S; Christensen D; Hansen SP; Cartwright GE
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):918-23. PubMed ID: 5791811
    [No Abstract]   [Full Text] [Related]  

  • 3. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION].
    AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI
    Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395
    [No Abstract]   [Full Text] [Related]  

  • 4. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal copper metabolism and hepatolenticular degeneration.
    DENNY-BROWN D
    Res Publ Assoc Res Nerv Ment Dis; 1953; 32():190-7. PubMed ID: 13134643
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatolenticular degeneration: a new metabolic disease].
    BOUDIN G; PEPIN B
    Presse Med (1893); 1954 Feb; 62(12):243-5. PubMed ID: 13145588
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue copper determinations in a case of hepatolenticular degeneration treated with BAL (dimercaprol).
    PALMER JF; DREW AL; CHENOWETH MB
    Med Bull (Ann Arbor); 1953 Nov; 19(11):308-11. PubMed ID: 13122933
    [No Abstract]   [Full Text] [Related]  

  • 10. [Disorders of copper and amino acid metabolism in hepato-cerebral degeneration and their treatment with BAL].
    STEGER J; STEGER R
    Dtsch Z Nervenheilkd; 1954; 172(4):321-51. PubMed ID: 14365436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advances in the study of hepatolenticular degeneration].
    Liu DK; Li NZ; Chen XZ; Yang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):248-51. PubMed ID: 3908020
    [No Abstract]   [Full Text] [Related]  

  • 12. [Wilson's disease (hepatolenticular degeneration)].
    Bickel H
    Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
    [No Abstract]   [Full Text] [Related]  

  • 13. [BAL therapy and copper excretion in hepatolenticular syndrome].
    ERDMANN-MULLER GJ; HORNBOSTEL H
    Klin Wochenschr; 1953 Dec; 31(45-46):1102-3. PubMed ID: 13118699
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
    Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
    [No Abstract]   [Full Text] [Related]  

  • 15. CHROMATOGRAPHIC AND MAGNETIC STUDIES ON HUMAN CERULOPLASMIN.
    BROMAN L
    Acta Soc Med Ups; 1964; 69():SUPPL 7:1-85. PubMed ID: 14229509
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and purification of a non-ceruloplasmin ferroxidase of human serum.
    Topham RW; Frieden E
    J Biol Chem; 1970 Dec; 245(24):6698-705. PubMed ID: 4098342
    [No Abstract]   [Full Text] [Related]  

  • 17. Wilson's disease (hepatolenticular degeneration) and pregnancy.
    Dreifuss FE; McKinney WM
    JAMA; 1966 Mar; 195(11):960-2. PubMed ID: 5951974
    [No Abstract]   [Full Text] [Related]  

  • 18. HEPATOLENTICULAR DEGENERATION; CLINICAL AND BIOCHEMICAL STUDY OF THREE CASES.
    CANELAS HM; ESCALANTE OD; DE JORGE FB; ROCHA-QINTAO EC
    Arq Neuropsiquiatr; 1963 Dec; 21():229-50. PubMed ID: 14119988
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity.
    Sunderman FW; Nomoto S
    Clin Chem; 1970 Nov; 16(11):903-10. PubMed ID: 5473551
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.